|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Inhibition of Rho Kinase (ROCK) Leads to Increased Cerebral Blood Flow and Stroke Protection显示文摘 | Yoshiyuki Rikitake Hyung-Hwan Kim Zhihong Huang Minoru Seto Kazuo Yano Toshio Asano Michael A. Moskowitz James K. Liao | 2005 | Stroke2005，，10： | 3 |
| 2 | Inhibition of Rho kinase (ROCK) leads to increased cerebral blood flow and stroke protection显示文摘 | Rikitake Y Kim HH Huang Z | 2005 | Stroke2005，36，10： | 1 |
| 3 | Cerivastatin suppresses lipopolysaccharide- induced ICAM-Ⅰ expression through inhibition ofRho GTPase in BAEC显示文摘 | Takeuchi S Kawashima S Rikitake Y | 2010 | Biochem Bio- phys Res Commun2010，269，1： | 1 |
| 4 | Inhibition of Rho kinase(ROCK) leads to increased cerebral blood flow and stroke protection 显示文摘 | Rikitake Y Kim HH Huang Z | 2005 | Stroke2005，36，10： | 1 |
| 5 | Complete resection of recurrent thymic carcinoid using cardiopulmonary bypass 显示文摘 | Sakuragi T Rikitake K Nastuaki M | 2002 | Eur J Cardiothorac Surg2002，21，1： | 1 |
| 6 | Inhibition of Rho - kinase (ROCK) leads to increased cerebral blood flow and stroke protection 显示文摘 | Rikitake Y Kim HH Huang Z | 2005 | Stroke2005，36，10： | 1 |
| 7 | Rho激酶的抑制可改善冠状动脉疾病患者的内皮功能显示文摘基础生物学研究提示Rho/Rho激酶通路激活可降低一氧化氮(NO)的生物利用度,进而促发动脉粥样硬化及其临床并发症。然而,关于动脉粥样硬化患者中Rho/Rho激酶通路与N0生物利用度之间的关系甚少报道。因此,作者拟确定Rho激酶的抑制是否可增加冠状动脉疾病(CAD)患者的NO生物利用度,改善其内皮功能。在一项双盲交叉对照试验中,13例CAD患者和16例年龄、性别与之匹配的健康对照者被随机入选接受Rho激酶抑制剂法舒地尔或安慰剂治疗各1月。 | Nohria A. Grunert M. E. Rikitake Y. 杜媛(译) 郭俊(校) | 2007 | 世界核心医学期刊文摘(心脏病学分册)2007，3，6： | 1 |
| 8 | Antioxidative properties of fluvastatin an HMG-CoA reductase inhibitor contribute to prevention of atherosclerosis in cholesterol fed rabbits 显示文摘 | Rikitake Y Kawashima S Takeshita S | 2001 | Atherosclerosis2001，154，1： | 1 |
| 9 | Rho kinase inhibition improves endothelial function in human subject with coronary artery disease显示文摘 | Nohria A Grunert ME Rikitake Y | 2006 | Circ Res2006，99，： | 1 |
| 10 | ROCK1 mediates leukocyte recruitment and neointima formation following vascular injury显示文摘 | Noma K Rikitake Y Oyama N | 2008 | J Clin Invest2008，118，5： | 1 |
| 11 | Inhibition of Rho ki2nase (ROCK) leads to increased cerebral blood flow and stroke protection 显示文摘 | Rikitake Y Kim HH Huang Z | 2005 | Stroke2005，36，10： | 1 |
| 12 | Expression of NADH/NADPH oxidase p22phox in human coronary arteries 显示文摘 | Azumi H Inoue N Takeshita S Rikitake Y Kawashima S Hayashi Y | 1999 | Circulation1999，100，： | 1 |
| 13 | Studies of the thermal state of the earth, part2-heat flow associated with magma intrusions 显示文摘 | Rikitake T | 1959 | Bull Earthq Inst1959，37，2： | 1 |
| 14 | Inhibition of Rho-kinase leads to rapid activation of hosphatidylinositol 3-kinase/protein kinase Akt and cardiovascular protection显示文摘 | Wolfrum S Dendorfer A Rikitake Y | 2004 | Arterioscler Thromb Vasc Biol2004，24，10： | 1 |
| 15 | Inhibition of Rhokinase (ROCK) leads to increased cerebral blood flow and stroke protection显示文摘 | RIKITAKE Y KIM H H HUANG Z | 2005 | Stroke2005，36，10： | 1 |
| 16 | Rho kinase inhibition improves endothelial function in human subjects with coronary artery disease 显示文摘 | NOHRI A A GRUNERT M E RIKITAKE Y | 2006 | Cire Res2006，99，12： | 1 |
| 17 | Inhibition of Rho kinase (ROCK) leads to increased cerebral blood flow and stroke protection 显示文摘 | Rikitake Y Kim HH Huang Z | 2005 | Stroke2005，36，10： | 1 |
| 18 | Rho GTPases, statins, and nitric oxide 显示文摘 | Rikitake Y Liao JK | 2005 | Circ Res2005，97，12： | 1 |
| 19 | Rho GTPases,statins,and nitric oxide显示文摘 | Rikitake Y Liao JK | 2005 | Circ Res2005，97，12： | 1 |
| 20 | Anti-oxidative properties of fluvastatin, an HMG-CoA reductase inhibitor, Contribute to prevention of atherodclerosis in cholesterol-fed rabbits显示文摘 | Rikitake Y Kawashima S Takeshita S | 2001 | Atherosclerosis2001，154，1： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员